High-Flow Nasal Cannula and Standard Oxygen in Acute Hypoxemic Respiratory Failure Due to COVID-19

REFERENCES

1. 1.↵
   1. Mannucci E,
   2. Silverii GA,
   3. Monami M

   . Saturation of critical care capacity and mortality in patients with the novel coronavirus (COVID-19) in Italy. Trends Anaesth. Crit. Care 2020;33(8):33-34.

   OpenUrlCrossRef
2. 2.↵
   1. Rodriguez-Llanes JM,
   2. Castro Delgado R,
   3. Pedersen MG,
   4. Meneghini M,
   5. Arcos González P

   . Surging critical care capacity for COVID-19: key now and in the future. Prog Disaster Sci 2020;8:100136.

   OpenUrl
3. 3.↵
   1. Zhang TT,
   2. Dai B,
   3. Wang W

   . Should the high-flow nasal oxygen therapy be used or avoided in COVID-19? J Transl Int Med 2020;8(2):57-58.

   OpenUrl
4. 4.↵
   1. Lyons C,
   2. Callaghan M

   . The use of high-flow nasal oxygen in COVID-19. Anaesthesia 2020;75(7):843-847.

   OpenUrlCrossRef
5. 5.↵
   1. Frat J-P,
   2. Thille AW,
   3. Mercat A,
   4. Girault C,
   5. Ragot S,
   6. Perbet S,
   7. et al

   ; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185-2196.

   OpenUrlCrossRefPubMed
6. 6.
   1. Frat JP,
   2. Ragot S,
   3. Girault C,
   4. Perbet S,
   5. Prat G,
   6. Boulain T,
   7. et al

   ; REVA network. Effect of noninvasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post hoc analysis of a randomized trial. Lancet Respir Med 2016;4(8):646-652.

   OpenUrl
7. 7.
   1. Mokart D,
   2. Geay C,
   3. Chow-Chine L,
   4. Brun JP,
   5. Faucher M,
   6. Blache JL,
   7. et al

   . High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med 2015;41(11):2008-2010.

   OpenUrlPubMed
8. 8.↵
   1. Roca O,
   2. de Acilu MG,
   3. Caralt B,
   4. Sacanell J,
   5. Masclans JR

   . Humidified high-flow nasal cannula supportive therapy improves outcomes in lung transplant recipients readmitted to the intensive care unit because of acute respiratory failure. Transplantation 2015;99(5):1092-1098.

   OpenUrlPubMed
9. 9.↵
   1. Mauri T,
   2. Turrini C,
   3. Eronia N,
   4. Grasselli G,
   5. Volta CA,
   6. Bellani G,
   7. Pesenti A

   . Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195(9):1207-1215.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Perkins GD,
    2. Ji C,
    3. Connolly BA,
    4. Couper K,
    5. Lall R,
    6. Baillie JK,
    7. et al

    . An adaptive randomized controlled trial of noninvasive respiratory strategies in acute respiratory failure patients with COVID-19. medRxiv 2021. doi: 10.1101/2021.08.02.21261379.

    OpenUrlCrossRef
11. 11.↵
    1. Ospina-Tascón GA,
    2. Calderón-Tapia LE,
    3. García AF,
    4. Zarama V,
    5. Gómez-Álvarez F,
    6. Álvarez-Saa T,
    7. et al

    ; on behalf of HiFLo-Covid Investigators. Effect of high-flow vs conventional oxygen therapy on invasive mechanical ventilation and recovery in severe COVID-19. JAMA 2021;326(21):2161-2171.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Alhazzani W,
    2. Møller MH,
    3. Arabi YM,
    4. Loeb M,
    5. Gong MN,
    6. Fan E,
    7. et al

    . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID19). Intensive Care Med 2020;46(5):854-887.

    OpenUrlCrossRefPubMed
13. 13.↵
    American Association for Respiratory Care. SARS CoV-2 Guidance Document. Available at: https://www.aarc.org/wp-content/uploads/2020/03/guidance-document-SARS-COVID19. Accessed May 14, 2020.
14. 14.↵
    1. Grasselli G,
    2. Zangrillo A,
    3. Zanella A,
    4. Antonelli M,
    5. Cabrini L,
    6. Castelli A,
    7. et al

    ; COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1,591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020;323(16):1574-1581.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Cummings MJ,
    2. Baldwin MR,
    3. Abrams D,
    4. Jacobson SD,
    5. Meyer BJ,
    6. Balough EM,
    7. et al

    . Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395(10239):1763-1770.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Gallo Marin B,
    2. Aghagoli G,
    3. Lavine K,
    4. Yang L,
    5. Siff EJ,
    6. Chiang SS,
    7. et al

    . Predictors of COVID-19 severity: a literature review. Rev Med Virol 2021;31(1):1-10.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M,
    4. Pocock SJ,
    5. Gotzsche PC,
    6. Vanderbroucke JP

    ; on behalf of STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLos Med 2007;4(10):e296

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Panadero C,
    2. Abad-Fernández A,
    3. Rio-Ramirez MT,
    4. Acosta-Gutierrez CM,
    5. Calderon-Alcala M,
    6. Lopez-Riolobos C,
    7. et al

    . High-flow nasal cannula for acute respiratory distress syndrome (ARDS) due to COVID-19. Multidiscip Respir Med 2020;15(1):693.

    OpenUrlCrossRefPubMed
19. 19.
    1. Chandel A,
    2. Patolia S,
    3. Brown AW,
    4. Collins AC,
    5. Sahjwani D,
    6. Khangoora V,
    7. et al

    . High-flow nasal cannula therapy in COVID-19: using the ROX index to predict success. Respir Care 2021;66(6):909-919.

    OpenUrlAbstract/FREE Full Text
20. 20.
    1. Hernandez-Romieu AC,
    2. Adelman MW,
    3. Hockstein MA,
    4. Robichaux CJ,
    5. Edwards JA,
    6. Fazio JC,
    7. et al

    ; on behalf of the Emory COVID-19 Quality and Clinical Research Collaborative. Timing of intubation and mortality among critically ill coronavirus disease 2019 patients: a single-center cohort study. Crit Care Med 2020;48(11):e1045-e1053.

    OpenUrlCrossRefPubMed
21. 21.
    1. Zucman N,
    2. Mullaert J,
    3. Roux D,
    4. Roca O,
    5. Ricard JD

    ; Contributors. Prediction of outcome of nasal high-flow use during COVID-19–related acute hypoxemic respiratory failure. Intensive Care Med 2020;46(10):1924-1926.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Yang X,
    2. Yu Y,
    3. Xu J,
    4. Shu H,
    5. Xia J,
    6. Liu H,
    7. et al

    . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-481. Erratum in: Lancet Respir Med 2020 Apr;8(4):e26.

    OpenUrl
23. 23.↵
    1. Franco C,
    2. Facciolongo N,
    3. Tonelli R,
    4. Dongilli R,
    5. Vianello A,
    6. Pisani L,
    7. et al

    . Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia. Eur Respir J 2020;56(5):2002130.

    OpenUrlPubMed
24. 24.↵
    COVID-ICU group, for the REVA network, COVID-ICU investigators. Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multi-center, prospective cohort study (COVID-ICU) in 137 hospitals. Crit Care 2021;25(1):421.

    OpenUrlCrossRef
25. 25.↵
    1. Bhatraju PK,
    2. Ghassemieh BJ,
    3. Nichols M,
    4. Kim R,
    5. Jerome KR,
    6. Nalla AK,
    7. et al

    . COVID-19 in critically ill patients in the Seattle region - case series. N Engl J Med 2020;382(21):2012-2022.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Boietti BR,
    2. Mirofsky M,
    3. Valentini R,
    4. Peuchot VA,
    5. Cámera LA,
    6. Pollán JA,
    7. et al

    ; on behalf of Grupo de Trabajo COVID-19. Descriptive analysis of 4,776 patients admitted to medical clinic services for COVID-19. Results of the Argentine Multi-Center Registry - REMA-COVID-19. Medicina (B Aires)2021;81(5):703-714.

    OpenUrl
27. 27.↵
    1. Tobin MJ,
    2. Jubran A,
    3. Laghi F

    . Noninvasive strategies in COVID-19: epistemology, randomized trials, guidelines, physiology. Eur Respir J 2021;57(2):2004247.

    OpenUrlAbstract/FREE Full Text